Top Pharma Stocks to Watch in May 2025

Sun Pharmaceutical Industries Ltd.: India's largest pharma company with strong domestic sales and expanding global specialty portfolio; Q3 profit surged 15% year-over-year

Dr. Reddy’s Laboratories Ltd.: Hyderabad-based firm with robust North American pipeline; Q4 profit up 36.5%, driven by strong U.S. generic sales

Cipla Ltd.: Leader in respiratory therapies; expanding U.S. presence with complex generics, bolstered by domestic growth in chronic and consumer health segments

Divi’s Laboratories Ltd.: Top API manufacturer with strong export business; focus on sustainable practices and custom synthesis ensures long-term growth prospects

Biocon Ltd.: Pioneer in biopharmaceuticals; strong presence in biosimilars and novel therapies, with global partnerships enhancing market access and scale